EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 69 filers reported holding EVELO BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -98.1% | 265 | -98.3% | 0.00% | – |
| Q1 2022 | $53,000 | -44.8% | 15,765 | 0.0% | 0.00% | – |
| Q4 2021 | $96,000 | +37.1% | 15,765 | +57.8% | 0.00% | – |
| Q3 2021 | $70,000 | -81.3% | 9,988 | -63.4% | 0.00% | – |
| Q2 2021 | $375,000 | +72.0% | 27,291 | +33.8% | 0.00% | – |
| Q1 2021 | $218,000 | +66.4% | 20,400 | +88.9% | 0.00% | – |
| Q4 2020 | $131,000 | +129.8% | 10,800 | 0.0% | 0.00% | – |
| Q3 2020 | $57,000 | +7.5% | 10,800 | 0.0% | 0.00% | – |
| Q2 2020 | $53,000 | +29.3% | 10,800 | 0.0% | 0.00% | – |
| Q1 2020 | $41,000 | -6.8% | 10,800 | 0.0% | 0.00% | – |
| Q4 2019 | $44,000 | -33.3% | 10,800 | 0.0% | 0.00% | – |
| Q3 2019 | $66,000 | -32.0% | 10,800 | 0.0% | 0.00% | – |
| Q2 2019 | $97,000 | +12.8% | 10,800 | 0.0% | 0.00% | – |
| Q1 2019 | $86,000 | -9.5% | 10,800 | +47.9% | 0.00% | – |
| Q4 2018 | $95,000 | +6.7% | 7,300 | 0.0% | 0.00% | – |
| Q3 2018 | $89,000 | +3.5% | 7,300 | 0.0% | 0.00% | – |
| Q2 2018 | $86,000 | – | 7,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 3,063,505 | $10,385,000 | 2.12% |
| Flagship Pioneering Inc. | 23,030,069 | $78,072,000 | 1.83% |
| Alphabet Inc. | 1,060,495 | $3,595,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 72,871 | $247,000 | 0.03% |
| Virtus ETF Advisers LLC | 21,013 | $71,000 | 0.03% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 1,100,000 | $3,729,000 | 0.02% |
| CREDIT SUISSE AG/ | 3,677,164 | $12,466,000 | 0.01% |
| Belvedere Trading LLC | 172,792 | $397,000 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 26,222 | $89,000 | 0.01% |
| FMR LLC | 8,046,489 | $27,277,000 | 0.00% |